<?xml version="1.0" encoding="utf-8"?>
<!--Generated by DFIN XBRL Instance Document - http://www.dfinsolutions.com/ - Version R3.0 - on 02-August-2020 [02:13:54] {PM}-->
<schema targetNamespace="http://www.galectintherapeutics.com/20200630" elementFormDefault="qualified" xmlns:galt="http://www.galectintherapeutics.com/20200630" xmlns="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:country="http://xbrl.sec.gov/country/2020-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2020-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2020-01-31" xmlns:naics="http://xbrl.sec.gov/naics/2017-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2020-01-31" xmlns:us-types="http://fasb.org/us-types/2020-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2018-01-31" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:srt-types="http://fasb.org/srt-types/2020-01-31">
<annotation>
<appinfo>
<link:roleType roleURI="http://www.galectintherapeutics.com/role/Cover" id="Cover">
<link:definition>1001 - Document - Cover</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.galectintherapeutics.com/role/CondensedConsolidatedBalanceSheetsUnaudited" id="CondensedConsolidatedBalanceSheetsUnaudited">
<link:definition>1002 - Statement - Condensed Consolidated Balance Sheets (Unaudited)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.galectintherapeutics.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical" id="CondensedConsolidatedBalanceSheetsUnauditedParenthetical">
<link:definition>1003 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.galectintherapeutics.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited" id="CondensedConsolidatedStatementsOfOperationsUnaudited">
<link:definition>1004 - Statement - Condensed Consolidated Statements of Operations (Unaudited)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.galectintherapeutics.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" id="CondensedConsolidatedStatementsOfCashFlowsUnaudited">
<link:definition>1005 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.galectintherapeutics.com/role/CondensedConsolidatedStatementsOfChangesInRedeemableConvertiblePreferredStockAndStockholdersEquityUnaudited" id="CondensedConsolidatedStatementsOfChangesInRedeemableConvertiblePreferredStockAndStockholdersEquityUnaudited">
<link:definition>1006 - Statement - Condensed Consolidated Statements of Changes in Redeemable Convertible Preferred Stock and Stockholders' Equity (Unaudited)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.galectintherapeutics.com/role/BasisOfPresentation" id="BasisOfPresentation">
<link:definition>1007 - Disclosure - Basis of Presentation</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.galectintherapeutics.com/role/AccruedExpensesAndOther" id="AccruedExpensesAndOther">
<link:definition>1008 - Disclosure - Accrued Expenses and Other</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.galectintherapeutics.com/role/LineOfCredit" id="LineOfCredit">
<link:definition>1009 - Disclosure - Line of Credit</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.galectintherapeutics.com/role/StockBasedCompensation" id="StockBasedCompensation">
<link:definition>1010 - Disclosure - Stock-Based Compensation</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.galectintherapeutics.com/role/CommonStockWarrants" id="CommonStockWarrants">
<link:definition>1011 - Disclosure - Common Stock Warrants</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.galectintherapeutics.com/role/FairValueOfFinancialInstruments" id="FairValueOfFinancialInstruments">
<link:definition>1012 - Disclosure - Fair Value of Financial Instruments</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.galectintherapeutics.com/role/LossPerShare" id="LossPerShare">
<link:definition>1013 - Disclosure - Loss Per Share</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.galectintherapeutics.com/role/CommonStock" id="CommonStock">
<link:definition>1014 - Disclosure - Common Stock</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.galectintherapeutics.com/role/PreferredStockConversionIntoCommonStock" id="PreferredStockConversionIntoCommonStock">
<link:definition>1015 - Disclosure - Preferred Stock Conversion into Common Stock</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.galectintherapeutics.com/role/CommitmentsAndContingencies" id="CommitmentsAndContingencies">
<link:definition>1016 - Disclosure - Commitments and Contingencies</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.galectintherapeutics.com/role/Leases" id="Leases">
<link:definition>1017 - Disclosure - Leases</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.galectintherapeutics.com/role/GalectinSciencesLlc" id="GalectinSciencesLlc">
<link:definition>1018 - Disclosure - Galectin Sciences LLC</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.galectintherapeutics.com/role/AccruedExpensesAndOtherTables" id="AccruedExpensesAndOtherTables">
<link:definition>1019 - Disclosure - Accrued Expenses and Other (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.galectintherapeutics.com/role/StockBasedCompensationTables" id="StockBasedCompensationTables">
<link:definition>1020 - Disclosure - Stock-Based Compensation (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.galectintherapeutics.com/role/CommonStockWarrantsTables" id="CommonStockWarrantsTables">
<link:definition>1021 - Disclosure - Common Stock Warrants (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.galectintherapeutics.com/role/LossPerShareTables" id="LossPerShareTables">
<link:definition>1022 - Disclosure - Loss Per Share (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.galectintherapeutics.com/role/LeasesTables" id="LeasesTables">
<link:definition>1023 - Disclosure - Leases (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.galectintherapeutics.com/role/BasisOfPresentationAdditionalInformationDetail" id="BasisOfPresentationAdditionalInformationDetail">
<link:definition>1024 - Disclosure - Basis of Presentation - Additional Information (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.galectintherapeutics.com/role/AccruedExpensesAndOtherDetail" id="AccruedExpensesAndOtherDetail">
<link:definition>1025 - Disclosure - Accrued Expenses and Other (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.galectintherapeutics.com/role/LineOfCreditAdditionalInformationDetail" id="LineOfCreditAdditionalInformationDetail">
<link:definition>1026 - Disclosure - Line of Credit - Additional Information (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.galectintherapeutics.com/role/StockBasedCompensationAdditionalInformationDetail" id="StockBasedCompensationAdditionalInformationDetail">
<link:definition>1027 - Disclosure - Stock-Based Compensation - Additional Information (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.galectintherapeutics.com/role/StockBasedCompensationExpenseRelatedToCommonStockOptionsRestrictedCommonStockAndCommonStockWarrantsDetail" id="StockBasedCompensationExpenseRelatedToCommonStockOptionsRestrictedCommonStockAndCommonStockWarrantsDetail">
<link:definition>1028 - Disclosure - Stock-Based Compensation Expense Related to Common Stock Options, Restricted Common Stock and Common Stock Warrants (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.galectintherapeutics.com/role/SummaryOfStockOptionActivityDetail" id="SummaryOfStockOptionActivityDetail">
<link:definition>1029 - Disclosure - Summary of Stock Option Activity (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.galectintherapeutics.com/role/WeightedAverageAssumptionsUsedToDetermineFairValueOfOptionsGrantedDetail" id="WeightedAverageAssumptionsUsedToDetermineFairValueOfOptionsGrantedDetail">
<link:definition>1030 - Disclosure - Weighted Average Assumptions Used to Determine Fair Value of Options Granted (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.galectintherapeutics.com/role/CommonStockWarrantActivityDetail" id="CommonStockWarrantActivityDetail">
<link:definition>1031 - Disclosure - Common Stock Warrant Activity (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.galectintherapeutics.com/role/CommonStockWarrantsParentheticalDetails" id="CommonStockWarrantsParentheticalDetails">
<link:definition>1032 - Disclosure - Common Stock Warrants (Parenthetical) (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.galectintherapeutics.com/role/DilutiveSharesWhichCouldExistPursuantToExerciseOfOutstandingStockInstrumentsAndWhichWereNotIncludedInCalculationDetail" id="DilutiveSharesWhichCouldExistPursuantToExerciseOfOutstandingStockInstrumentsAndWhichWereNotIncludedInCalculationDetail">
<link:definition>1033 - Disclosure - Dilutive Shares Which Could Exist Pursuant to Exercise of Outstanding Stock Instruments and Which were not Included in Calculation (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.galectintherapeutics.com/role/CommonStockAdditionalInformationDetail" id="CommonStockAdditionalInformationDetail">
<link:definition>1034 - Disclosure - Common Stock - Additional Information (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.galectintherapeutics.com/role/PreferredStockConversionIntoCommonStockAdditionalInformationDetail" id="PreferredStockConversionIntoCommonStockAdditionalInformationDetail">
<link:definition>1035 - Disclosure - Preferred Stock Conversion into Common Stock  - Additional Information (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.galectintherapeutics.com/role/LeasesAdditionalInformationDetail" id="LeasesAdditionalInformationDetail">
<link:definition>1036 - Disclosure - Leases Additional Information (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.galectintherapeutics.com/role/LeasesMaturityOfOperatingLeaseDetails" id="LeasesMaturityOfOperatingLeaseDetails">
<link:definition>1037 - Disclosure - Leases - Maturity of operating lease (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.galectintherapeutics.com/role/GalectinScienceLlcAdditionalInformationDetail" id="GalectinScienceLlcAdditionalInformationDetail">
<link:definition>1038 - Disclosure - Galectin Science LLC - Additional Information (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:linkbaseRef xlink:type="simple" xlink:href="galt-20200630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
<link:linkbaseRef xlink:type="simple" xlink:href="galt-20200630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
<link:linkbaseRef xlink:type="simple" xlink:href="galt-20200630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
<link:linkbaseRef xlink:type="simple" xlink:href="galt-20200630_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
</appinfo>
</annotation>
<import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
<import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
<import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
<import namespace="http://fasb.org/us-gaap/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd" />
<import namespace="http://xbrl.sec.gov/country/2020-01-31" schemaLocation="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd" />
<import namespace="http://xbrl.sec.gov/currency/2020-01-31" schemaLocation="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd" />
<import namespace="http://xbrl.sec.gov/exch/2020-01-31" schemaLocation="https://xbrl.sec.gov/exch/2020/exch-2020-01-31.xsd" />
<import namespace="http://xbrl.sec.gov/naics/2017-01-31" schemaLocation="https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd" />
<import namespace="http://xbrl.sec.gov/sic/2020-01-31" schemaLocation="https://xbrl.sec.gov/sic/2020/sic-2020-01-31.xsd" />
<import namespace="http://xbrl.sec.gov/stpr/2018-01-31" schemaLocation="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd" />
<import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
<import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
<import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
<import namespace="http://xbrl.sec.gov/dei/2019-01-31" schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd" />
<import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
<import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
<import namespace="http://fasb.org/us-types/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd" />
<import namespace="http://fasb.org/srt-types/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd" />
<import namespace="http://fasb.org/srt/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd" />
<element name="SeriesAConvertiblePreferredStockMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="galt_SeriesAConvertiblePreferredStockMember" substitutionGroup="xbrli:item" />
<element name="AccruedAndOtherLiabilitiesCurrent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="galt_AccruedAndOtherLiabilitiesCurrent" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="UndesignatedCapitalStockValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="galt_UndesignatedCapitalStockValue" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="UndesignatedCapitalStockParValue" type="num:perShareItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="galt_UndesignatedCapitalStockParValue" substitutionGroup="xbrli:item" />
<element name="UndesignatedCapitalStockSharesAuthorized" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="galt_UndesignatedCapitalStockSharesAuthorized" substitutionGroup="xbrli:item" />
<element name="UndesignatedCapitalStockSharesOutstanding" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="galt_UndesignatedCapitalStockSharesOutstanding" substitutionGroup="xbrli:item" />
<element name="NonCashExpenseRelatedToExtensionOfWarrants" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="galt_NonCashExpenseRelatedToExtensionOfWarrants" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="SupplementalDividendsOnConvertiblePreferredStock" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="galt_SupplementalDividendsOnConvertiblePreferredStock" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="PaymentOfPreferredStockDividends" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="galt_PaymentOfPreferredStockDividends" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="SeriesBOneConvertiblePreferredStockMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="galt_SeriesBOneConvertiblePreferredStockMember" substitutionGroup="xbrli:item" />
<element name="SeriesBTwoConvertiblePreferredStockMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="galt_SeriesBTwoConvertiblePreferredStockMember" substitutionGroup="xbrli:item" />
<element name="StockBThreeConvertiblePreferredStockMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="galt_StockBThreeConvertiblePreferredStockMember" substitutionGroup="xbrli:item" />
<element name="SeriesBConvertiblePreferredStockMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="galt_SeriesBConvertiblePreferredStockMember" substitutionGroup="xbrli:item" />
<element name="SeriesAOnePreferredStockMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="galt_SeriesAOnePreferredStockMember" substitutionGroup="xbrli:item" />
<element name="SeriesBOnePreferredStockMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="galt_SeriesBOnePreferredStockMember" substitutionGroup="xbrli:item" />
<element name="SeriesBThreePreferredStockMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="galt_SeriesBThreePreferredStockMember" substitutionGroup="xbrli:item" />
<element name="SeriesBTwoPreferredStockMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="galt_SeriesBTwoPreferredStockMember" substitutionGroup="xbrli:item" />
<element name="AdjustmentsToAdditionalPaidInCapitalDividendsInDeficitOfRetainedEarnings" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="galt_AdjustmentsToAdditionalPaidInCapitalDividendsInDeficitOfRetainedEarnings" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="StockIssuedDuringPeriodValueWarrantsAndOptionsExercised" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="galt_StockIssuedDuringPeriodValueWarrantsAndOptionsExercised" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="StockIssuedDuringPeriodSharesWarrantsAndOptionsExercised" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="galt_StockIssuedDuringPeriodSharesWarrantsAndOptionsExercised" substitutionGroup="xbrli:item" />
<element name="WarrantsAndOptionsAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="galt_WarrantsAndOptionsAxis" substitutionGroup="xbrldt:dimensionItem" />
<element name="WarrantsAndOptionsDomain" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="galt_WarrantsAndOptionsDomain" substitutionGroup="xbrli:item" />
<element name="AccruedAndOtherLiabilitiesCurrentDisclosureTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="galt_AccruedAndOtherLiabilitiesCurrentDisclosureTextBlock" substitutionGroup="xbrli:item" />
<element name="StockWarrantsTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="galt_StockWarrantsTextBlock" substitutionGroup="xbrli:item" />
<element name="ConversionOfPreferredStockToCommonStockDisclosureTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="galt_ConversionOfPreferredStockToCommonStockDisclosureTextBlock" substitutionGroup="xbrli:item" />
<element name="BasisOfPresentationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="galt_BasisOfPresentationAbstract" substitutionGroup="xbrli:item" />
<element name="BasisOfPresentationLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="galt_BasisOfPresentationLineItems" substitutionGroup="xbrli:item" />
<element name="CurrentlyEstimatedCostsOfTrailAndGeneralOverhead" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="galt_CurrentlyEstimatedCostsOfTrailAndGeneralOverhead" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="ScheduleOfAccruedLiabilitiesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="galt_ScheduleOfAccruedLiabilitiesTable" substitutionGroup="xbrldt:hypercubeItem" />
<element name="ScheduleOfAccruedLiabilitiesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="galt_ScheduleOfAccruedLiabilitiesLineItems" substitutionGroup="xbrli:item" />
<element name="AccruedResearchAndDevelopmentCostsAndOther" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="galt_AccruedResearchAndDevelopmentCostsAndOther" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="UnsecuredLineOfCreditMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="galt_UnsecuredLineOfCreditMember" substitutionGroup="xbrli:item" />
<element name="IssuanceOfWarrantsValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="galt_IssuanceOfWarrantsValue" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="NonEmployeeBoardOfDirectorsOneMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="galt_NonEmployeeBoardOfDirectorsOneMember" substitutionGroup="xbrli:item" />
<element name="NonEmployeeBoardOfDirectorsTwoMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="galt_NonEmployeeBoardOfDirectorsTwoMember" substitutionGroup="xbrli:item" />
<element name="SharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsweightedaverageexercisepriceAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="galt_SharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsweightedaverageexercisepriceAbstract" substitutionGroup="xbrli:item" />
<element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice" type="num:perShareItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="galt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice" substitutionGroup="xbrli:item" />
<element name="AggregateOfferingPrice" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="galt_AggregateOfferingPrice" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="CommissionsAsPercentageOfGrossOfferingProceeds" type="num:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="galt_CommissionsAsPercentageOfGrossOfferingProceeds" substitutionGroup="xbrli:item" />
<element name="PrivatePlacementTwentySeventeenMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="galt_PrivatePlacementTwentySeventeenMember" substitutionGroup="xbrli:item" />
<element name="TwoThousandSeventeenAtMarketSalesAgreementMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="galt_TwoThousandSeventeenAtMarketSalesAgreementMember" substitutionGroup="xbrli:item" />
<element name="OtherAgreementsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="galt_OtherAgreementsMember" substitutionGroup="xbrli:item" />
<element name="TwoThousandTwentyAtMarketSalesAgreementMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="galt_TwoThousandTwentyAtMarketSalesAgreementMember" substitutionGroup="xbrli:item" />
<element name="ModificationsToWarrantsAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="galt_ModificationsToWarrantsAxis" substitutionGroup="xbrldt:dimensionItem" />
<element name="ModificationsToWarrantsDomain" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="galt_ModificationsToWarrantsDomain" substitutionGroup="xbrli:item" />
<element name="SeriesB1B2AndB3ConvertiblePreferredStockMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="galt_SeriesB1B2AndB3ConvertiblePreferredStockMember" substitutionGroup="xbrli:item" />
<element name="NumberOfWarrantsIssued" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="galt_NumberOfWarrantsIssued" substitutionGroup="xbrli:item" />
<element name="BeforeModificationOfTermsOfWarrantsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="galt_BeforeModificationOfTermsOfWarrantsMember" substitutionGroup="xbrli:item" />
<element name="AfterModificationOfTermsOfWarrantsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="galt_AfterModificationOfTermsOfWarrantsMember" substitutionGroup="xbrli:item" />
<element name="TenXFundLPMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="galt_TenXFundLPMember" substitutionGroup="xbrli:item" />
<element name="LeaseDeposits" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="galt_LeaseDeposits" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="AccruedAndOtherLiabilitiesCurrentMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="galt_AccruedAndOtherLiabilitiesCurrentMember" substitutionGroup="xbrli:item" />
<element name="SbhSciencesIncMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="galt_SbhSciencesIncMember" substitutionGroup="xbrli:item" />
<element name="FairValueOfAssetContributedToJointVenture" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="galt_FairValueOfAssetContributedToJointVenture" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="GalectinSciencesLlcMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="galt_GalectinSciencesLlcMember" substitutionGroup="xbrli:item" />
</schema>
